Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.
D015250:Aclarubicin; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008875:Middle Aged; D009279:Naphthacenes / Q000627:therapeutic use / Q000633:toxicity
D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D015250:Aclarubicin